Westlake Chemical Partners LP (NYSE:WLKP) Q4 2019 Earnings Conference Call February 18, 2020 12:00 PM ET Company Participants Jeff Holy - Vice President & Treasurer Albert Chao - President & Chief Executive Officer Steve Bender - Senior Vice President & Chief Financial Officer Conference Call Participants Matthew Blair - Tudor, Pickering, Holt Mike Whitehead - Barclays Operator Good morning. Thank you for standing by. Welcome to the Westlake Chemical Partners Fourth Quarter and Full Year 2019 Earnings Confe ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File No. 001-36567 Westlake Chemical Partners LP (713) 585-2900 (Registrant's telephone number, including area code) Securities registered pursuant to ...

Westlake Chemical Partners LP (NYSE:WLKP) Q3 2019 Earnings Conference Call November 5, 2019 12:00 PM ET Company Participants Jeff Holy - VP and Treasurer Albert Chao - President and CEO Steven Bender - SVP and CFO Conference Call Participants Neel Kumar - Morgan Stanley Steven Berman - Bank of America Merrill Lynch Kevin McCarthy - Vertical Research Partners Bob Koort - Goldman Sachs Mike Whitehead - Barclays Capital Arun Viswanathan - RBC Capital Markets Jim Sheehan - SunTrust Robinson Humphrey Hassan Ahme ...

Westlake Chemical Partners LP. (NYSE:WLKP) Q2 2019 Results Earnings Conference Call August 6, 2019 12:00 PM ET Company Participants Jeff Holy - Westlake Chemical Partners' Vice President and Treasurer Albert Chao - President and CEO Steven Bender - Senior Vice President and CFO Conference Call Participants Mike Leithead - Barclays Matthew Blair - Tudor, Pickering, Holt Jon Evans - SG Capital Paul Leming - Water Street Capital Operator Good morning. Thank you for standing by. Welcome to the Westlake Chemical ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File No. 001-36567 Westlake Chemical Partners LP (Exact name of Registrant as specified in its charter) Delaware 32-0436529 (State or other jurisdiction of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File No. 001-36567 Westlake Chemical Partners LP Delaware 32-0436529 (I.R.S. Employer Identification Number) 2801 Post Oak Boulevard, Suite 600 Houston, Te ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File No. 001-36567 Westlake Chemical Partners LP (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorp ...